Investigational Drug Information for Tricaprilin
✉ Email this page to a colleague
What is the drug development status for Tricaprilin?
Tricaprilin is an investigational drug.
There have been 14 clinical trials for Tricaprilin.
The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2024.
The most common disease conditions in clinical trials are Alzheimer Disease, Spasm, and Migraine Disorders. The leading clinical trial sponsors are Cerecin, Accera, Inc., and [disabled in preview].
There are one hundred and twenty-three US patents protecting this investigational drug and zero international patents.
Summary for Tricaprilin
US Patents | 123 |
International Patents | 5,035 |
US Patent Applications | 1,907 |
WIPO Patent Applications | 245 |
Japanese Patent Applications | 4,434 |
Clinical Trial Progress | Phase 2 (2024-01-01) |
Vendors | 54 |
Recent Clinical Trials for Tricaprilin
Title | Sponsor | Phase |
---|---|---|
Tricaprilin Phase 3 AD Study | Cerecin | Phase 3 |
AC-OLE-01-VA Tolerability Study in Healthy Participants Under Different Dosing Conditions | Cerecin | Phase 1 |
A Phase 1, Two-part, Randomized Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Liquid Formulation of Tricaprilin and Matching Placebo in Healthy Subjects | Cerecin | Phase 1 |
Clinical Trial Summary for Tricaprilin
Top disease conditions for Tricaprilin
Top clinical trial sponsors for Tricaprilin
US Patents for Tricaprilin
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
Tricaprilin | ⤷ Sign Up | Ammonia oxidizing bacteria for treatment of eczema | AOBIOME LLC (Cambridge, MA) | ⤷ Sign Up |
Tricaprilin | ⤷ Sign Up | Easily formulated zinc oxide powder | BASF SE (Ludwigshafen, DE) | ⤷ Sign Up |
Tricaprilin | ⤷ Sign Up | Treatments for resistant acne | VYOME BIOSCIENNCES PVT. LTD. (New Delhi, IN) | ⤷ Sign Up |
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Tricaprilin
Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
---|---|---|---|---|
Tricaprilin | China | CN103189046 | 2030-09-09 | ⤷ Sign Up |
Tricaprilin | China | CN106074278 | 2030-09-09 | ⤷ Sign Up |
Tricaprilin | World Intellectual Property Organization (WIPO) | WO2012033634 | 2030-09-09 | ⤷ Sign Up |
>Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |